nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Irinotecan—colon cancer	0.106	0.143	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.106	0.143	CbGbCtD
Alprazolam—CYP3A7—Vincristine—colon cancer	0.0929	0.125	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0929	0.125	CbGbCtD
Alprazolam—CYP2C9—Capecitabine—colon cancer	0.0865	0.116	CbGbCtD
Alprazolam—CYP3A5—Irinotecan—colon cancer	0.0797	0.107	CbGbCtD
Alprazolam—CYP3A5—Vincristine—colon cancer	0.0697	0.0937	CbGbCtD
Alprazolam—CYP2C9—Fluorouracil—colon cancer	0.0513	0.069	CbGbCtD
Alprazolam—CYP3A4—Irinotecan—colon cancer	0.0311	0.0418	CbGbCtD
Alprazolam—CYP3A4—Vincristine—colon cancer	0.0272	0.0365	CbGbCtD
Alprazolam—Sweating increased—Capecitabine—colon cancer	0.000661	0.00259	CcSEcCtD
Alprazolam—Ill-defined disorder—Irinotecan—colon cancer	0.000655	0.00256	CcSEcCtD
Alprazolam—Vertigo—Vincristine—colon cancer	0.000651	0.00255	CcSEcCtD
Alprazolam—Abdominal discomfort—Capecitabine—colon cancer	0.00065	0.00254	CcSEcCtD
Alprazolam—Hepatic failure—Methotrexate—colon cancer	0.00065	0.00254	CcSEcCtD
Alprazolam—Vision blurred—Fluorouracil—colon cancer	0.000637	0.00249	CcSEcCtD
Alprazolam—Malaise—Irinotecan—colon cancer	0.000637	0.00249	CcSEcCtD
Alprazolam—Vertigo—Irinotecan—colon cancer	0.000634	0.00248	CcSEcCtD
Alprazolam—Dysuria—Capecitabine—colon cancer	0.000634	0.00248	CcSEcCtD
Alprazolam—Syncope—Irinotecan—colon cancer	0.000633	0.00248	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Capecitabine—colon cancer	0.00063	0.00247	CcSEcCtD
Alprazolam—Convulsion—Vincristine—colon cancer	0.000628	0.00246	CcSEcCtD
Alprazolam—Loss of consciousness—Irinotecan—colon cancer	0.00062	0.00243	CcSEcCtD
Alprazolam—Photosensitivity reaction—Capecitabine—colon cancer	0.000619	0.00242	CcSEcCtD
Alprazolam—Myalgia—Vincristine—colon cancer	0.000617	0.00242	CcSEcCtD
Alprazolam—Weight increased—Capecitabine—colon cancer	0.000617	0.00242	CcSEcCtD
Alprazolam—Weight decreased—Capecitabine—colon cancer	0.000613	0.0024	CcSEcCtD
Alprazolam—Infestation—Capecitabine—colon cancer	0.000605	0.00237	CcSEcCtD
Alprazolam—Infestation NOS—Capecitabine—colon cancer	0.000605	0.00237	CcSEcCtD
Alprazolam—Depression—Capecitabine—colon cancer	0.000603	0.00236	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000599	0.00235	CcSEcCtD
Alprazolam—Lethargy—Methotrexate—colon cancer	0.000596	0.00233	CcSEcCtD
Alprazolam—Discomfort—Irinotecan—colon cancer	0.000594	0.00232	CcSEcCtD
Alprazolam—Oedema—Vincristine—colon cancer	0.000592	0.00232	CcSEcCtD
Alprazolam—Jaundice—Capecitabine—colon cancer	0.000589	0.00231	CcSEcCtD
Alprazolam—Infection—Vincristine—colon cancer	0.000588	0.0023	CcSEcCtD
Alprazolam—Convulsion—Fluorouracil—colon cancer	0.000586	0.00229	CcSEcCtD
Alprazolam—Osteoarthritis—Methotrexate—colon cancer	0.000584	0.00229	CcSEcCtD
Alprazolam—Confusional state—Irinotecan—colon cancer	0.000581	0.00227	CcSEcCtD
Alprazolam—Nervous system disorder—Vincristine—colon cancer	0.00058	0.00227	CcSEcCtD
Alprazolam—Oedema—Irinotecan—colon cancer	0.000576	0.00226	CcSEcCtD
Alprazolam—Chest pain—Fluorouracil—colon cancer	0.000576	0.00225	CcSEcCtD
Alprazolam—Myalgia—Fluorouracil—colon cancer	0.000576	0.00225	CcSEcCtD
Alprazolam—Infection—Irinotecan—colon cancer	0.000572	0.00224	CcSEcCtD
Alprazolam—Hyperhidrosis—Vincristine—colon cancer	0.000572	0.00224	CcSEcCtD
Alprazolam—Hepatobiliary disease—Capecitabine—colon cancer	0.000572	0.00224	CcSEcCtD
Alprazolam—Epistaxis—Capecitabine—colon cancer	0.00057	0.00223	CcSEcCtD
Alprazolam—Discomfort—Fluorouracil—colon cancer	0.000569	0.00223	CcSEcCtD
Alprazolam—Shock—Irinotecan—colon cancer	0.000567	0.00222	CcSEcCtD
Alprazolam—Nervous system disorder—Irinotecan—colon cancer	0.000565	0.00221	CcSEcCtD
Alprazolam—Anorexia—Vincristine—colon cancer	0.000564	0.00221	CcSEcCtD
Alprazolam—Irritability—Methotrexate—colon cancer	0.000557	0.00218	CcSEcCtD
Alprazolam—Hyperhidrosis—Irinotecan—colon cancer	0.000557	0.00218	CcSEcCtD
Alprazolam—Confusional state—Fluorouracil—colon cancer	0.000556	0.00218	CcSEcCtD
Alprazolam—Mood swings—Methotrexate—colon cancer	0.000553	0.00217	CcSEcCtD
Alprazolam—Hypotension—Vincristine—colon cancer	0.000553	0.00216	CcSEcCtD
Alprazolam—Oedema—Fluorouracil—colon cancer	0.000552	0.00216	CcSEcCtD
Alprazolam—Anorexia—Irinotecan—colon cancer	0.000549	0.00215	CcSEcCtD
Alprazolam—Ataxia—Methotrexate—colon cancer	0.000549	0.00215	CcSEcCtD
Alprazolam—Infection—Fluorouracil—colon cancer	0.000548	0.00215	CcSEcCtD
Alprazolam—Hepatitis—Capecitabine—colon cancer	0.000543	0.00212	CcSEcCtD
Alprazolam—Nervous system disorder—Fluorouracil—colon cancer	0.000541	0.00212	CcSEcCtD
Alprazolam—Hypoaesthesia—Capecitabine—colon cancer	0.00054	0.00211	CcSEcCtD
Alprazolam—Liver function test abnormal—Methotrexate—colon cancer	0.000539	0.00211	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Vincristine—colon cancer	0.000539	0.00211	CcSEcCtD
Alprazolam—Tachycardia—Fluorouracil—colon cancer	0.000539	0.00211	CcSEcCtD
Alprazolam—Hypotension—Irinotecan—colon cancer	0.000538	0.00211	CcSEcCtD
Alprazolam—Urinary tract disorder—Capecitabine—colon cancer	0.000536	0.0021	CcSEcCtD
Alprazolam—Insomnia—Vincristine—colon cancer	0.000535	0.00209	CcSEcCtD
Alprazolam—Oedema peripheral—Capecitabine—colon cancer	0.000535	0.00209	CcSEcCtD
Alprazolam—Connective tissue disorder—Capecitabine—colon cancer	0.000533	0.00209	CcSEcCtD
Alprazolam—Urethral disorder—Capecitabine—colon cancer	0.000532	0.00208	CcSEcCtD
Alprazolam—Paraesthesia—Vincristine—colon cancer	0.000531	0.00208	CcSEcCtD
Alprazolam—Breast disorder—Methotrexate—colon cancer	0.000528	0.00207	CcSEcCtD
Alprazolam—Anorexia—Fluorouracil—colon cancer	0.000526	0.00206	CcSEcCtD
Alprazolam—Insomnia—Irinotecan—colon cancer	0.000521	0.00204	CcSEcCtD
Alprazolam—Paraesthesia—Irinotecan—colon cancer	0.000517	0.00203	CcSEcCtD
Alprazolam—Hypotension—Fluorouracil—colon cancer	0.000516	0.00202	CcSEcCtD
Alprazolam—Decreased appetite—Vincristine—colon cancer	0.000514	0.00201	CcSEcCtD
Alprazolam—Dyspnoea—Irinotecan—colon cancer	0.000514	0.00201	CcSEcCtD
Alprazolam—Erythema multiforme—Capecitabine—colon cancer	0.000513	0.00201	CcSEcCtD
Alprazolam—Somnolence—Irinotecan—colon cancer	0.000512	0.002	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Vincristine—colon cancer	0.000511	0.002	CcSEcCtD
Alprazolam—Fatigue—Vincristine—colon cancer	0.00051	0.002	CcSEcCtD
Alprazolam—Eye disorder—Capecitabine—colon cancer	0.000507	0.00199	CcSEcCtD
Alprazolam—Dyspepsia—Irinotecan—colon cancer	0.000507	0.00199	CcSEcCtD
Alprazolam—Tinnitus—Capecitabine—colon cancer	0.000506	0.00198	CcSEcCtD
Alprazolam—Constipation—Vincristine—colon cancer	0.000506	0.00198	CcSEcCtD
Alprazolam—Cardiac disorder—Capecitabine—colon cancer	0.000504	0.00197	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000503	0.00197	CcSEcCtD
Alprazolam—Decreased appetite—Irinotecan—colon cancer	0.000501	0.00196	CcSEcCtD
Alprazolam—Insomnia—Fluorouracil—colon cancer	0.000499	0.00195	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Irinotecan—colon cancer	0.000497	0.00195	CcSEcCtD
Alprazolam—Fatigue—Irinotecan—colon cancer	0.000497	0.00194	CcSEcCtD
Alprazolam—Paraesthesia—Fluorouracil—colon cancer	0.000495	0.00194	CcSEcCtD
Alprazolam—Constipation—Irinotecan—colon cancer	0.000493	0.00193	CcSEcCtD
Alprazolam—Angiopathy—Capecitabine—colon cancer	0.000492	0.00193	CcSEcCtD
Alprazolam—Dyspnoea—Fluorouracil—colon cancer	0.000492	0.00193	CcSEcCtD
Alprazolam—Somnolence—Fluorouracil—colon cancer	0.000491	0.00192	CcSEcCtD
Alprazolam—Mediastinal disorder—Capecitabine—colon cancer	0.000489	0.00191	CcSEcCtD
Alprazolam—Chills—Capecitabine—colon cancer	0.000487	0.00191	CcSEcCtD
Alprazolam—Dyspepsia—Fluorouracil—colon cancer	0.000486	0.0019	CcSEcCtD
Alprazolam—Abdominal discomfort—Methotrexate—colon cancer	0.000484	0.00189	CcSEcCtD
Alprazolam—Gastrointestinal pain—Vincristine—colon cancer	0.000484	0.00189	CcSEcCtD
Alprazolam—Decreased appetite—Fluorouracil—colon cancer	0.00048	0.00188	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000476	0.00186	CcSEcCtD
Alprazolam—Mental disorder—Capecitabine—colon cancer	0.000476	0.00186	CcSEcCtD
Alprazolam—Feeling abnormal—Irinotecan—colon cancer	0.000475	0.00186	CcSEcCtD
Alprazolam—Malnutrition—Capecitabine—colon cancer	0.000472	0.00185	CcSEcCtD
Alprazolam—Dysuria—Methotrexate—colon cancer	0.000472	0.00185	CcSEcCtD
Alprazolam—Gastrointestinal pain—Irinotecan—colon cancer	0.000471	0.00184	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Methotrexate—colon cancer	0.000469	0.00184	CcSEcCtD
Alprazolam—Body temperature increased—Vincristine—colon cancer	0.000468	0.00183	CcSEcCtD
Alprazolam—Abdominal pain—Vincristine—colon cancer	0.000468	0.00183	CcSEcCtD
Alprazolam—Photosensitivity reaction—Methotrexate—colon cancer	0.000461	0.0018	CcSEcCtD
Alprazolam—Back pain—Capecitabine—colon cancer	0.000457	0.00179	CcSEcCtD
Alprazolam—Abdominal pain—Irinotecan—colon cancer	0.000455	0.00178	CcSEcCtD
Alprazolam—Body temperature increased—Irinotecan—colon cancer	0.000455	0.00178	CcSEcCtD
Alprazolam—Feeling abnormal—Fluorouracil—colon cancer	0.000455	0.00178	CcSEcCtD
Alprazolam—Muscle spasms—Capecitabine—colon cancer	0.000454	0.00178	CcSEcCtD
Alprazolam—Infestation NOS—Methotrexate—colon cancer	0.00045	0.00176	CcSEcCtD
Alprazolam—Infestation—Methotrexate—colon cancer	0.00045	0.00176	CcSEcCtD
Alprazolam—Drowsiness—Methotrexate—colon cancer	0.00045	0.00176	CcSEcCtD
Alprazolam—Depression—Methotrexate—colon cancer	0.000449	0.00176	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000446	0.00175	CcSEcCtD
Alprazolam—Vision blurred—Capecitabine—colon cancer	0.000445	0.00174	CcSEcCtD
Alprazolam—Tremor—Capecitabine—colon cancer	0.000443	0.00173	CcSEcCtD
Alprazolam—Ill-defined disorder—Capecitabine—colon cancer	0.000438	0.00172	CcSEcCtD
Alprazolam—Urticaria—Fluorouracil—colon cancer	0.000438	0.00172	CcSEcCtD
Alprazolam—Body temperature increased—Fluorouracil—colon cancer	0.000436	0.00171	CcSEcCtD
Alprazolam—Hypersensitivity—Vincristine—colon cancer	0.000436	0.00171	CcSEcCtD
Alprazolam—Sweating—Methotrexate—colon cancer	0.000431	0.00169	CcSEcCtD
Alprazolam—Malaise—Capecitabine—colon cancer	0.000426	0.00167	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—colon cancer	0.000426	0.00167	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—colon cancer	0.000425	0.00166	CcSEcCtD
Alprazolam—Vertigo—Capecitabine—colon cancer	0.000424	0.00166	CcSEcCtD
Alprazolam—Hypersensitivity—Irinotecan—colon cancer	0.000424	0.00166	CcSEcCtD
Alprazolam—Asthenia—Vincristine—colon cancer	0.000424	0.00166	CcSEcCtD
Alprazolam—Syncope—Capecitabine—colon cancer	0.000424	0.00166	CcSEcCtD
Alprazolam—Palpitations—Capecitabine—colon cancer	0.000418	0.00163	CcSEcCtD
Alprazolam—Loss of consciousness—Capecitabine—colon cancer	0.000415	0.00163	CcSEcCtD
Alprazolam—Asthenia—Irinotecan—colon cancer	0.000413	0.00162	CcSEcCtD
Alprazolam—Hypersensitivity—Fluorouracil—colon cancer	0.000407	0.00159	CcSEcCtD
Alprazolam—Diarrhoea—Vincristine—colon cancer	0.000405	0.00158	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—colon cancer	0.000404	0.00158	CcSEcCtD
Alprazolam—Myalgia—Capecitabine—colon cancer	0.000402	0.00157	CcSEcCtD
Alprazolam—Chest pain—Capecitabine—colon cancer	0.000402	0.00157	CcSEcCtD
Alprazolam—Arthralgia—Capecitabine—colon cancer	0.000402	0.00157	CcSEcCtD
Alprazolam—Anxiety—Capecitabine—colon cancer	0.000401	0.00157	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000399	0.00156	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—colon cancer	0.000399	0.00156	CcSEcCtD
Alprazolam—Discomfort—Capecitabine—colon cancer	0.000397	0.00156	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—colon cancer	0.000396	0.00155	CcSEcCtD
Alprazolam—Diarrhoea—Irinotecan—colon cancer	0.000394	0.00154	CcSEcCtD
Alprazolam—Dry mouth—Capecitabine—colon cancer	0.000393	0.00154	CcSEcCtD
Alprazolam—Dizziness—Vincristine—colon cancer	0.000391	0.00153	CcSEcCtD
Alprazolam—Pruritus—Fluorouracil—colon cancer	0.00039	0.00153	CcSEcCtD
Alprazolam—Confusional state—Capecitabine—colon cancer	0.000389	0.00152	CcSEcCtD
Alprazolam—Oedema—Capecitabine—colon cancer	0.000386	0.00151	CcSEcCtD
Alprazolam—Infection—Capecitabine—colon cancer	0.000383	0.0015	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—colon cancer	0.000382	0.0015	CcSEcCtD
Alprazolam—Dizziness—Irinotecan—colon cancer	0.000381	0.00149	CcSEcCtD
Alprazolam—Shock—Capecitabine—colon cancer	0.000379	0.00148	CcSEcCtD
Alprazolam—Nervous system disorder—Capecitabine—colon cancer	0.000378	0.00148	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—colon cancer	0.000378	0.00148	CcSEcCtD
Alprazolam—Diarrhoea—Fluorouracil—colon cancer	0.000378	0.00148	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—colon cancer	0.000377	0.00147	CcSEcCtD
Alprazolam—Tachycardia—Capecitabine—colon cancer	0.000376	0.00147	CcSEcCtD
Alprazolam—Vomiting—Vincristine—colon cancer	0.000376	0.00147	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—colon cancer	0.000375	0.00147	CcSEcCtD
Alprazolam—Skin disorder—Capecitabine—colon cancer	0.000375	0.00147	CcSEcCtD
Alprazolam—Rash—Vincristine—colon cancer	0.000373	0.00146	CcSEcCtD
Alprazolam—Hyperhidrosis—Capecitabine—colon cancer	0.000373	0.00146	CcSEcCtD
Alprazolam—Dermatitis—Vincristine—colon cancer	0.000373	0.00146	CcSEcCtD
Alprazolam—Headache—Vincristine—colon cancer	0.000371	0.00145	CcSEcCtD
Alprazolam—Anorexia—Capecitabine—colon cancer	0.000368	0.00144	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—colon cancer	0.000367	0.00143	CcSEcCtD
Alprazolam—Vomiting—Irinotecan—colon cancer	0.000366	0.00143	CcSEcCtD
Alprazolam—Dizziness—Fluorouracil—colon cancer	0.000365	0.00143	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—colon cancer	0.000364	0.00143	CcSEcCtD
Alprazolam—Rash—Irinotecan—colon cancer	0.000363	0.00142	CcSEcCtD
Alprazolam—Dermatitis—Irinotecan—colon cancer	0.000363	0.00142	CcSEcCtD
Alprazolam—Chills—Methotrexate—colon cancer	0.000363	0.00142	CcSEcCtD
Alprazolam—Headache—Irinotecan—colon cancer	0.000361	0.00141	CcSEcCtD
Alprazolam—Hypotension—Capecitabine—colon cancer	0.00036	0.00141	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—colon cancer	0.000354	0.00139	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—colon cancer	0.000352	0.00138	CcSEcCtD
Alprazolam—Nausea—Vincristine—colon cancer	0.000351	0.00138	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000351	0.00138	CcSEcCtD
Alprazolam—Vomiting—Fluorouracil—colon cancer	0.000351	0.00137	CcSEcCtD
Alprazolam—Insomnia—Capecitabine—colon cancer	0.000349	0.00137	CcSEcCtD
Alprazolam—Rash—Fluorouracil—colon cancer	0.000348	0.00136	CcSEcCtD
Alprazolam—Dermatitis—Fluorouracil—colon cancer	0.000348	0.00136	CcSEcCtD
Alprazolam—Paraesthesia—Capecitabine—colon cancer	0.000346	0.00136	CcSEcCtD
Alprazolam—Headache—Fluorouracil—colon cancer	0.000346	0.00135	CcSEcCtD
Alprazolam—Dyspnoea—Capecitabine—colon cancer	0.000344	0.00135	CcSEcCtD
Alprazolam—Nausea—Irinotecan—colon cancer	0.000342	0.00134	CcSEcCtD
Alprazolam—Back pain—Methotrexate—colon cancer	0.00034	0.00133	CcSEcCtD
Alprazolam—Dyspepsia—Capecitabine—colon cancer	0.000339	0.00133	CcSEcCtD
Alprazolam—Decreased appetite—Capecitabine—colon cancer	0.000335	0.00131	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Capecitabine—colon cancer	0.000333	0.0013	CcSEcCtD
Alprazolam—Fatigue—Capecitabine—colon cancer	0.000332	0.0013	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—colon cancer	0.000331	0.0013	CcSEcCtD
Alprazolam—Constipation—Capecitabine—colon cancer	0.00033	0.00129	CcSEcCtD
Alprazolam—Nausea—Fluorouracil—colon cancer	0.000328	0.00128	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—colon cancer	0.000326	0.00128	CcSEcCtD
Alprazolam—Feeling abnormal—Capecitabine—colon cancer	0.000318	0.00124	CcSEcCtD
Alprazolam—Malaise—Methotrexate—colon cancer	0.000317	0.00124	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—colon cancer	0.000316	0.00124	CcSEcCtD
Alprazolam—Gastrointestinal pain—Capecitabine—colon cancer	0.000315	0.00123	CcSEcCtD
Alprazolam—Urticaria—Capecitabine—colon cancer	0.000306	0.0012	CcSEcCtD
Alprazolam—Body temperature increased—Capecitabine—colon cancer	0.000305	0.00119	CcSEcCtD
Alprazolam—Abdominal pain—Capecitabine—colon cancer	0.000305	0.00119	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—colon cancer	0.000305	0.00119	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—colon cancer	0.000299	0.00117	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—colon cancer	0.000299	0.00117	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—colon cancer	0.000299	0.00117	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000297	0.00116	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—colon cancer	0.000296	0.00116	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—colon cancer	0.000289	0.00113	CcSEcCtD
Alprazolam—Infection—Methotrexate—colon cancer	0.000285	0.00112	CcSEcCtD
Alprazolam—Hypersensitivity—Capecitabine—colon cancer	0.000284	0.00111	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—colon cancer	0.000282	0.0011	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—colon cancer	0.000279	0.00109	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—colon cancer	0.000278	0.00109	CcSEcCtD
Alprazolam—Asthenia—Capecitabine—colon cancer	0.000277	0.00108	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—colon cancer	0.000274	0.00107	CcSEcCtD
Alprazolam—Pruritus—Capecitabine—colon cancer	0.000273	0.00107	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—colon cancer	0.000268	0.00105	CcSEcCtD
Alprazolam—Diarrhoea—Capecitabine—colon cancer	0.000264	0.00103	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000262	0.00102	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—colon cancer	0.00026	0.00102	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—colon cancer	0.000258	0.00101	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—colon cancer	0.000256	0.001	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—colon cancer	0.000255	0.000999	CcSEcCtD
Alprazolam—Dizziness—Capecitabine—colon cancer	0.000255	0.000998	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—colon cancer	0.000253	0.000989	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—colon cancer	0.00025	0.000977	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—colon cancer	0.000248	0.00097	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—colon cancer	0.000247	0.000969	CcSEcCtD
Alprazolam—Vomiting—Capecitabine—colon cancer	0.000245	0.00096	CcSEcCtD
Alprazolam—Rash—Capecitabine—colon cancer	0.000243	0.000952	CcSEcCtD
Alprazolam—Dermatitis—Capecitabine—colon cancer	0.000243	0.000951	CcSEcCtD
Alprazolam—Headache—Capecitabine—colon cancer	0.000242	0.000946	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—colon cancer	0.000237	0.000926	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—colon cancer	0.000235	0.000919	CcSEcCtD
Alprazolam—Ketazolam—ABCB1—colon cancer	0.00023	0.27	CrCbGaD
Alprazolam—Nausea—Capecitabine—colon cancer	0.000229	0.000897	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—colon cancer	0.000228	0.000893	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—colon cancer	0.000227	0.000888	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—colon cancer	0.000227	0.000888	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—colon cancer	0.000211	0.000828	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—colon cancer	0.000206	0.000806	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—colon cancer	0.000203	0.000795	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—colon cancer	0.000196	0.000769	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—colon cancer	0.00019	0.000743	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—colon cancer	0.000183	0.000714	CcSEcCtD
Alprazolam—Rash—Methotrexate—colon cancer	0.000181	0.000708	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—colon cancer	0.000181	0.000708	CcSEcCtD
Alprazolam—Headache—Methotrexate—colon cancer	0.00018	0.000704	CcSEcCtD
Alprazolam—Nausea—Methotrexate—colon cancer	0.000171	0.000667	CcSEcCtD
Alprazolam—Clobazam—ABCB1—colon cancer	0.000163	0.191	CrCbGaD
Alprazolam—Nitrazepam—ABCB1—colon cancer	0.000134	0.158	CrCbGaD
Alprazolam—Flurazepam—ABCB1—colon cancer	0.00012	0.14	CrCbGaD
Alprazolam—Midazolam—ABCB1—colon cancer	0.000111	0.13	CrCbGaD
Alprazolam—Diazepam—ABCB1—colon cancer	9.5e-05	0.111	CrCbGaD
